Knacke’s money maps: Health is wealth
In his new monthly column, Ernst Knacke, head of research at Shard Capital, looks at the life sciences and biotech space
In his new monthly column, Ernst Knacke, head of research at Shard Capital, looks at the life sciences and biotech space
|
|
How fund group distribution bosses are thinking about asset classes, strategies and working with clients over the next 12 months
|
|
Square Mile’s Alex Farlow checks out the top performers and compelling newcomers
|
|
Banks that have thrived on high interest rates can continue to do so in a low-rate world, explains Sebastiano Pirro
|
|
Portfolio Adviser asks a panel of experts whether they see cryptocurrency becoming more widely adopted by the mainstream going forward
|
|
Companies such as TenCent, Samsung and TSMC were returning value to shareholders before the likes of Alphabet, says Yoojeong Oh
|
|
The director of UK wholesale distribution discusses cost pressures, market unpredictability and paradigm shifts
|
|
Workplaces that encourage diversity of thought reap notable business benefits, writes Baroness Helena Morrissey
|
|
Pension fund allocations to the UK are dwindling, but David Beggs says Labour could reinvigorate domestic investment
|
|
The portfolio manager on the next phase of the global economy, how skilled managers can get an edge on the machines and the danger of following the crowd
|
|
A weakening dollar, downturn in equities, and commanding fiscal policy could steer markets for the rest of the year, writes Jim Caron
|
|
JTC Groups’ Simon Gordon explains how the renewables trust sector is showing signs of recovery
|
|